Hemorrhagic Complications of Long-term Anticoagulant Therapy
CHEST JournalPublished 1 February 1989
Mark Levine, Gary E. Raskob, Jack Hirsh
Citations164
SJR quartileQ1
SJR score1.83
SNIP1.83
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The use of anticoagulant therapy in combination with chemotherapy to treat Hemorrhagic Complications of Long-term Chest Disease is still a viable treatment option for these patients.
Abstract
The main complication of anticoagulation therapy is bleeding. We have conducted a literature review to determine: (a) the rate of bleeding during long-term anticoagulant therapy in various clinical disorders, and (b) the clinical and laboratory risk factors that predispose patients to bleeding. For the purposes of this review, we defined long-term therapy as lasting greater than 4 weeks. Hemorrhagic complications were also described for 2 other indications, myocardial infarction and hip surgery, where oral anticoagulant therapy was used for a shorter duration (approximately 4 weeks).
Keywords
Medicine
New England Journal of MedicineDifferent Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis
735 Citations1982R. Hull, J. Hirsh +10 more
It is indicated that less intense anticoagulant therapy is associated with a low frequency of recurrent venous thromboembolism and a reduced risk of hemorrhage.
New England Journal of MedicineWarfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis
609 Citations1979Russell D. Hull, Terry Delmore +6 more
Adjust-dose warfarin sodium is more effective than low-dose subcutaneous heparin in preventing recurrent venous thromboembolism, but its use is accompanied by a significant risk of bleeding.
The LancetNEED FOR LONG-TERM ANTICOAGULANT TREATMENT IN SYMPTOMATIC CALF-VEIN THROMBOSIS
569 Citations1985C Lagerstedt
The findings indicate that oral anticoagulants should be given to all patients with thrombi that produce symptoms and that treatment for 3 months seems to be sufficient.
New England Journal of MedicineAdjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis
444 Citations1982Russell D. Hull, Terry Delmore +6 more
New England Journal of MedicinePharmacologic Control of Thromboembolic Complications of Cardiac-Valve Replacement
352 Citations1971Jay M. Sullivan, Dwight E. Harken +1 more
The LancetRANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT
317 Citations1988A. G. G. Turpie, Jack Hirsh +3 more
The less intensive regimen is no less effective and safer than standard anticoagulant therapy in patients with tissue heart valve replacement and Haemorrhagic complications were significantly more frequent with standard treatment than with the lessintensive regimen.
The American Journal of CardiologyTrial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamole
302 Citations1983James H. Chesebro, Valentı́n Fuster +9 more
Longer follow-up study is needed to determine whether further separation of the incidence of thromboembolism can be detected and whether warfarin plus aspirin therapy resulted in excessive bleeding and is contraindicated.
The LancetA DOUBLE-BLIND TRIAL TO ASSESS LONG-TERM ORAL ANTICOAGULANT THERAPY IN ELDERLY PATIENTS AFTER MYOCARDIAL INFARCTION
253 Citations1980Sixty Plus Reinfarction Study Research Group
A double-blind trial to assess longterm oral anticoagulant therapy in elderly patients after myocardial infarction and a 7-year analysis of haemorrhage in patients on long-term anticoAGulant treatment.
HeartA 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment.
198 Citations1979J C Forfar
Outpatients treated between 1970 and 1977, comprising 1199 patient-years of treat-ment, have been analysed in an attempt to clarify the iatrogenic risks of haemorrhage associated with oral anticoagulant treatment.
BMJAssessment of Short-term Anticoagulant Administration after Cardiac Infarction
192 Citations1969
There was a significant reduction in the frequency of clinically evident thromboembolic complications among patients in the high-dosage group and this did not, however, materially affect the difference in mortality from all causes.
American Heart JournalPrevention of arterial thromboembolism with acetylsalicylic acid
187 Citations1977Jon Dale, Erik Myhre +3 more
Journal of Thoracic and Cardiovascular SurgeryAspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves
172 Citations1976Raúl Altman, Fernando Boullón +4 more
It is concluded that the use of an anticoagulant plus aspirin is a good and safe therapy for the prevention of thromboembolism in patients with cardiac valve replacement.
Postgraduate Medical JournalMitral valve disease, systemic embolism and anticoagulants
147 Citations1971H A Fleming, Sheila Marie Bailey
Long-term treatment with anticoagulants appears to offer a good degree of protection to mitral valve disease patients and, provided the control of the treatment is good, the risks arising from it are small and less than the risks of embolism.
New England Journal of MedicineA Controlled Comparison of Aspirin and Oral Anticoagulants in Prevention of Death after Myocardial Infarction
139 Citations1982The E.P.S.I.M. Research Group
Aspirin in the dosage used in probably not different from oral anticoagulants in affecting mortality and morbidity after a myocardial infarction is concluded.
JAMAAnticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction
133 Citations1972Arnold Drapkin
Seminars in Thrombosis and HemostasisPrevention of Venous Thromboembolism
122 Citations2008Alexander Gallus, Jack Hirsh
The evidence suggests that oral anticoagulant treatment starting in the immediate postoperative period may not prevent formation of the initial thrombotic nidus, but is clinically effective because it prevents extension of the ndus to form a significant thrombus.
JAMAAnticoagulant Therapy After Acute Myocardial Infarction
116 Citations1972Arnold Drapkin
The value of anticoagulant therapy after acute myocardial infarction has been assessed in 1,136 patients admitted to the Bronx Municipal Hospital Center, and the treatment reduced the overall mortality in women from 31% to 15%, particularly those 55 years of age or over, with moderately severe infarctions.
HaemostasisSecondary Prevention of Myocardial Infarction: a Comparison of Acetylsalicylic Acid, Placebo and Phenprocoumon
108 Citations2009K Breddin, D Loew +3 more
A multicenter clinical trial on the prevention of recurrent myocardial infarction was started in 1970 and continued until March 1977, with results reported in June 1977.
StrokeAnticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks.
107 Citations1980J E Olsson, C Brechter +6 more
Compared to the natural history of untreated TIA/RIND both treatments were found to have a prophylactic effect against cerebral infarction.
New England Journal of MedicineAnticoagulation for Prevention of Thromboembolism Following Fractures of the Hip
102 Citations1966Edwin W. Salzman, William H. Harris +1 more
Patients with fractures of the hip are especially prone to the development of venous thromboses, which accounts for much of the morbidity and mortality that follow major trauma.
Acta Medica ScandinavicaOne‐Month versus Six‐Month Therapy with Oral Anticoagulants after Symptomatic Deep Vein Thrombosis
102 Citations1985K Holmgren, GUNNAR ANDERSSON +6 more
The recurrence rate during the first year was high (17% symptomatic recurrences) irrespective of whether OA had been given for one or six months, and the length of time for which deep vein thrombosis should be treated with oral anticoagulants was controversial.
American Heart JournalBleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement
95 Citations1980Jon Dale, Eric Myhre +1 more
It was concluded that the higher incidence of gastrointestinal bleeding in patients who received ASA and anticoagulants than in those on anticoageulants alone was acceptable when compared to the antithrombotic effect achieved with the combined treatment.
Journal of Bone and Joint Surgery - British VolumeVENOUS THROMBOSIS IN PATIENTS WITH FRACTURE OF THE UPPER END OF THE FEMUR
95 Citations1970Henry Hamilton, J. Selwyn Crawford +2 more
Analysis of the complete series failed to show that the incidence of venous thrombosis in the anticoagulation group was significantly less than in the control group, and no correlation was found in the select series.
The LancetWARFARIN SODIUM IN PREVENTION OF DEEP VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN PATIENTS WITH FRACTURED NECK OF FEMUR
93 Citations1976George K. Morris, J.R.A. Mitchell
In a prospective controlled randomised trial, the prophylactic value of warfarin sodium was assessed in 160 elderly patients who had sustained a fracture of the femoral neck and the difference in mortality between the treatment and control groups was not significant, indicating that causes of death other than pulmonary embolism are of major importance in these elderly patients.
BMJCerebrovascular Disease: Trial of Long-term Anticoagulant Therapy
87 Citations1962A. Bradford Hill, John Marshall +1 more
The trial was modified by withdrawing those who were hypertensive, and the further progress of the trial in its modified form to its conclusion in October, 1961 is reported.
Mayo Clinic ProceedingsHemostasis and Thrombosis
79 Citations1985J. N. Shanberge
Even though it is written mainly by authors who do not speak English, the book is easy to read and will be an appealing book for those interested in the history and the natural course of "periodic psychoses".
The American Journal of MedicineLow-dose heparin therapy in the long-term management of venous thromboembolism
65 Citations1979Lincoln Bynum, James Wilson
Self-administered, low-dose heparin therapy is a useful alternative to warfarin in the long-term management of complicated thromboembolic disorders.
British journal of surgeryControlled trial of an anticoagulant (warfarin sodium) in the prevention of venous thrombosis following hip surgery
58 Citations1970Donald Pinto
A prospective study was undertaken to assess the value of warfarin sodium, given prophylactically, in the prevention of postoperative deep‐vein thrombosis, and the results obtained were compared with physical signs of the disease process and phlebography.
Acta Medica ScandinavicaDOUBLE BLIND TRIAL OF LONG‐TERM ANTICOAGULANT TREATMENT AFTER MYOCARDIAL INFARCTION
54 Citations1969O J Meuwissen, A. C. Vervoorn +3 more
The fact that in the original placebo group the results remained less favourable even after the switch to phenprocoumon emphasizes the necessity of long-term treatment with adequate doses of anticoagulants following myocardial infarction.
QJMA-CONTROLLED CLINICAL TRIAL OF LONG-TERM ANTICOAGULANT THERAPY IN CEREBROVASCULAR DISEASE
53 Citations1960A. BRADFORD HILL, John Marshall +1 more
Thrombosis and HaemostasisPrevention of Venous Thromboembolism
52 Citations1979Salzman Ew
Confusion concerning the best form of prophylaxis for different patient groups, difficulty in translating results of clinical trials directly into practice, and ignorance of the dollar cost of the various regimes mean determination of cost/effectiveness of preventive programs is possible and can provide a workable guide to clinical practice.
Archives of NeurologyAnticoagulant Therapy
40 Citations1963Fletcher McDowell
This study was designed to test the thesis that anticoagulant therapy is of value in the prevention of further thrombo-embolic phenomena such as second strokes, pulmonary emboli, and myocardial infarction in patients with an established stroke.
JAMAControlled Study of the Effective Level of Long-Term Anticoagulation
36 Citations1964Christos B. Moschos, Peter Wong +1 more
In an attempt to determine the proper range of long-term anticoagulation, a group of patients under treatment were divided into three treatment groups, intensive, moderate, and control; the moderately treated patients fared the best overall.
The American Journal of CardiologyAnticoagulant therapy after acute myocardial infarction
35 Citations1990Alexander G.G. Turpie
The study used the development of left ventricular mural thrombosis, a frequent complication of acute myocardial infarction that carries a high risk for systemic embolic complications, to assess clinical outcome and suggests that monitoring plasma heparin levels and anticoagulant response can ensure maximal treatment effectiveness.
Archives of Internal MedicineFurther Experience with Long-Term Anticoagulant Therapy
27 Citations1955William T. Foley
The need for continuous administration of anticoagulants became apparent early in the clinical use of these drugs.
The American Journal of CardiologyTherapeutic level in long term anticoagulant therapy after myocardial infarction
25 Citations1963C Bjerkelund
Recurrent infarction is a better parameter than mortality from cardio-vascular causes for the evaluation of the antithrombic effect of anticoagulants in coronary diesease.
Thrombosis and HaemostasisThe Influence of Low Molecular Weight Heparin in Combination with Dihydroergotamine on Experimental Thrombosis and Haemostasis
3 Citations1987David Bergqvist, Bodil Nilsson
By combining low molecular weight heparin in a low dose with DHE it is possible to prevent thrombus formation without influencing primary haemostasis in rabbits.